Viavi Solutions Inc. (NASDAQ:VIAV) Given Average Rating of “Moderate Buy” by Analysts

Chronological Source Flow
Back

AI Fusion Summary

Viavi Solutions (VIAV) has moderate buy consensus from nine analysts: one sell, two holds, six buys; 12‑month target $25.00. MBX Biosciences (MBX) has a moderate buy consensus from twelve analysts: one strong buy, nine buys, two sells; 1‑year target $53.25.
#VIAVI_SOLUTIONS #MBX_BIOSCIENCES #MODERATE_BUY #ANALYST_RATINGS #MARKETBEAT #WALL_STREET_ZEN #SUSQUEHANNA #WEISS_RATINGS
20/04 09:38 defenseworld.net
3 Πηγές

Viavi Solutions Inc. (NASDAQ:VIAV) Given Average Rating of “Moderate Buy” by Analysts

CONSENSUS RATING ARTICLESPOLITICSCOMPANIES
20/04 09:56 defenseworld.net

MBX Biosciences, Inc. (NASDAQ:MBX) Given Consensus Rating of “Moderate Buy” by Analysts

POLITICSCONSENSUS RATING ARTICLESCOMPANIES
20/04 11:09 defenseworld.net

VAT Group AG – Unsponsored ADR (OTCMKTS:VACNY) Given Consensus Rating of “Moderate Buy” by Analysts

POLITICSCONSENSUS RATING ARTICLESCOMPANIESECONOMY
Comments
Loading...
0